CD4 and cancer: Although Foxp3 is considered as a specific marker of CD4+ regulatory T cells, it was also reported to express in non-Treg immune cells as well as non-immune cells, including CD8+ T cells, γδ T cells, NKT cells, B cells, macrophages, and cancer cells (28–31, 38, 39).